Prof Mark Gumbleton - BPharm MSc PhD MRPharmS
Following undergraduate studies in Pharmacy and completion of professional registration, Professor Gumbleton undertook postgraduate studies and fellowships in Clinical Pharmacology and Biopharmaceutics at the University of Aberdeen Medical School, School of Pharmacy Cardiff University and the Medical Centre at the University of California-San Francisco. After this he was appointed to the academic staff at the Universities of Strathclyde and Glasgow. Back in the USA he spent time as a visiting researcher at GeneMedicine Inc. before taking up an academic appointment at Cardiff University where he currently holds a Professorial appointment.
Prof Mark Gumbleton part of School’s engagement event (Monmouth Science Initiative)
Research activities include understanding at the whole body, tissue, cellular and molecular levels the interaction of experimental therapeutics with biological barriers, particularly the blood-brain-barrier. In experimental therapeutics Professor Gumbleton has a particular interest cancer therapeutics with respect to brain tumours.
Professor Gumbleton is currently Executive Editor for Advanced Drug Delivery Reviews, a journal publishing high quality thematic reviews on a wide range of Advanced Drug Delivery topics.
He has published over:
- 90 full-length peer reviewed research publications;
- 20 journal series, authored textbook chapters or edited books;
- 116 conference abstracts or editorials;
- Supervised 25 successful Ph.D. students;
- 24 postdoctoral/visiting scientists.
Prof Gumbleton has also served on a number of pan-European scientific steering committees in drug delivery and as organiser/ scientific programme organiser for International scientific meetings and also serves as consultant to pharmaceutical industry in USA and UK and is Director of Research at the School of Pharmacy and Pharmaceutical Sciences, Cardiff University.